IND Swift Limited — Loratadine Exporter Profile
Indian Pharmaceutical Exporter · #11 for Loratadine · $2.0M export value · DGFT Verified
IND Swift Limited is the #11 Indian exporter of Loratadine with $2.0M in export value and 88 verified shipments. IND Swift Limited holds a 1.2% market share in Loratadine exports across 5 countries. The company exports 13 pharmaceutical products worth $36.7M across 9 therapeutic categories.
IND Swift Limited — Loratadine Export Profile: Buyers & Destinations
Where Does IND Swift Limited Export Loratadine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALAYSIA | $810.4K | 42 | 47.6% |
| CHILE | $743.2K | 36 | 43.6% |
| UNITED ARAB EMIRATES | $118.6K | 6 | 7.0% |
| OMAN | $16.0K | 1 | 0.9% |
| IRAQ | $14.7K | 3 | 0.9% |
IND Swift Limited exports Loratadine to 5 countries. The largest destination is MALAYSIA accounting for 47.6% of IND Swift Limited's Loratadine shipments, followed by CHILE (43.6%) and UNITED ARAB EMIRATES (7.0%). These destinations reflect IND Swift Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Loratadine from IND Swift Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ASCEND LABORATORIES SPA, | CHILE | $633.9K | 22 |
| APEX PHARMACY MARKETING SDN BHD | MALAYSIA | $546.3K | 13 |
| SYNERRV SDN BHD. | MALAYSIA | $214.1K | 28 |
| LIFE PHARMA FZE | UNITED ARAB EMIRATES | $104.5K | 3 |
| ASCEND LABORATORIES SPA | CHILE | $58.9K | 7 |
| APEX PHARMACY MARKETING SDN BHD. | MALAYSIA | $50.0K | 1 |
| ASCEND LABORATORIES SPA,,. | CHILE | $36.7K | 3 |
| AL HASHAR PHARMACY LLC | OMAN | $16.0K | 1 |
| LEADERS SCIENTIFIC BUREAU | IRAQ | $14.7K | 3 |
| BIOVENTURE HEALTHCARE FZE | UNITED ARAB EMIRATES | $14.0K | 3 |
IND Swift Limited supplies Loratadine to 11 buyers globally. The largest buyer is ASCEND LABORATORIES SPA, (CHILE), followed by APEX PHARMACY MARKETING SDN BHD (MALAYSIA) and SYNERRV SDN BHD. (MALAYSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Loratadine Export Value and How Much Does IND Swift Limited Contribute?
India exported $49.6M worth of Loratadine through 4,321 shipments from 347 suppliers to 131 countries, serving 909 buyers globally. IND Swift Limited contributes $2.0M to this total, accounting for 1.2% of India's Loratadine exports. IND Swift Limited ships Loratadine to 5 countries through 11 buyers.
What Is the Average Shipment Value for IND Swift Limited's Loratadine Exports?
IND Swift Limited's average Loratadine shipment value is $23.1K per consignment, based on 88 shipments totaling $2.0M. The largest destination is MALAYSIA (47.6% of IND Swift Limited's Loratadine exports).
How Does IND Swift Limited Compare to Other Indian Loratadine Exporters?
IND Swift Limited ranks #11 among 347 Indian Loratadine exporters with a 1.2% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($10.8M), MARKSANS PHARMA LIMITED ($7.9M), SANDOZ PRIVATE LIMITED ($4.5M). IND Swift Limited processed 88 shipments to 5 destination countries.
What Loratadine Formulations Does IND Swift Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DESLORATADINA 5 MG (DESLORATADINE 5 MG T | $417.7K | 12 |
| AVORIUS 5MG TABLETS(DESLORATADINE 5 MG)1 | $300.0K | 6 |
| AVORIUS 5MG TAB DESLORATADINE 5 MG 1X10TB NO ALX10123 MFG FEB 2023 EXP JAN 2025 PACKS 160800X1X10 1608000 NOS | $100.0K | 2 |
| AVORIUS 5MG TABLETS(DESLORATADINE 5MG)1X | $99.0K | 2 |
| TAMIDES 5 MG (DESLORATADINE 5 MG TABLET | $83.6K | 3 |
| DESTALIFE 5 MG TAB DESLORATADINE TAB USP5MG 1X10T B NO APT11622 APT11722 APT11822 APT11922 MFG SEP 2022 EXP AUG 2025 | $50.0K | 1 |
| AVORIUS TABLET- (DESLORATADINE 5 MG) BATCH NO. ALX10324 MFG. DEC 2024 EXP. NOV 2026 (158370 X 10T = 1583700 NOS) | $50.0K | 1 |
| AVORIUS 5 MG TABLETS (DESLORATADINE TABLETS- 5 MG) BATCH NO. ALX10124 MFG.MAR 2024 EXP. FEB 2026 (158800X1X10T) | $47.3K | 3 |
| TAMIDES 5 MG (DESLORATADINE TABLETS 5 MG | $44.2K | 2 |
| SYNERRV DESLORATADINE 5 MG (DESLORATADINE 5 MG) BATCH NO.ALY10424 MFG.MAY-2024,EXP.APR-2026 (16128X100=1612800 NOS) | $43.5K | 1 |
IND Swift Limited exports 39 distinct Loratadine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DESLORATADINA 5 MG (DESLORATADINE 5 MG T with 12 shipments worth $417.7K.
How Does IND Swift Limited Compare to Nearest Loratadine Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | MEDREICH LIMITED | $2.3M | 203 | 7 | $11.4K |
| 7 | LUPIN LIMITED | $2.0M | 41 | 1 | $50.0K |
| 11 | IND SWIFT LIMITED ★ | $2.0M | 88 | 5 | $23.1K |
| 12 | CAPLIN POINT LABORATORIES LIMITED | $1.5M | 116 | 7 | $13.0K |
| 13 | ZYDUS LIFESCIENCES LIMITED | $1.5M | 94 | 13 | $15.6K |
IND Swift Limited ranks #11 among 347 Indian Loratadine exporters. Average shipment value of $23.1K compared to the market average of $142.8K. The closest competitors by value are MEDREICH LIMITED and LUPIN LIMITED.
Which Indian Ports Ship Loratadine Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 584 | 13.5% |
| JNPT/ NHAVA SHEVA SEA | 312 | 7.2% |
| SAHAR AIR | 289 | 6.7% |
| JNPT | 252 | 5.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 227 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 198 | 4.6% |
| DELHI AIR | 183 | 4.2% |
| HYDERABAD ICD | 113 | 2.6% |
What Other Antihistamines & Allergy Products Does IND Swift Limited Export?
IND Swift Limited also exports these antihistamines & allergy products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on IND Swift Limited's Loratadine Exports
Ind-Swift Laboratories' export operations have been influenced by recent geopolitical developments. The Israel-Iran conflict has heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes, impacting the company's logistics and cost structures. (livemint.com)
Conversely, the India–European Union Free Trade Agreement (India–EU FTA), concluded in January 2026, is poised to benefit Indian pharmaceutical exporters. The agreement eliminates tariffs on most European pharmaceutical imports, enhancing the competitiveness of Indian products in the EU market. This development presents an opportunity for Ind-Swift Laboratories to expand its footprint in Europe. (en.wikipedia.org)
In the United States, the reshoring of pharmaceutical manufacturing and potential imposition of tariffs on imports pose challenges for Indian exporters. While there are currently no import duties on Indian pharmaceutical products entering the US, the introduction of tariffs could affect the profitability of low-margin generic drugs, potentially leading to market exits. (cfo.economictimes.indiatimes.com)
IND Swift Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains paramount for Indian pharmaceutical exporters. Ind-Swift Laboratories has demonstrated a commitment to quality by adhering to Good Manufacturing Practices (GMP) as stipulated by the US FDA, WHO, and EU authorities. The company's manufacturing facilities in Punjab and Jammu have been inspected and approved by these regulatory bodies, facilitating access to regulated markets.
The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates continuous investment in quality systems and supply chain transparency. Ind-Swift Laboratories' focus on high-margin formulations underscores the importance of maintaining stringent quality standards to meet global regulatory requirements and sustain market access.
About IND Swift Limited
IND Swift Limited exports 13 products worth $36.7M. Beyond Loratadine, top products include Fexofenadine, Ramipril, Clarithromycin, Ezetimibe, Terbinafine. View the complete IND Swift Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Loratadine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Loratadine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: IND Swift Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 88 individual customs records matching IND Swift Limited exporting Loratadine, covering 39 formulations to 5 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 909+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Loratadine Export Data from IND Swift Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for IND Swift Limited's Loratadine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
IND Swift Limited
Full Company Profile →
13 products · $36.7M total trade · 9 categories
Loratadine Stats
Company Overview
Top Products by IND Swift Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for IND Swift Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Loratadine. For current shipment-level data, contact TransData Nexus.